6DCG

Discovery of MK-8353: An Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology


Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.


Version NumberVersion DateVersion Type/Reason Version ChangeRevised CIF Category
1.02018-08-08Initial release
1.12023-10-11Data collection, Database references, Refinement descriptionchem_comp_atom, chem_comp_bond, database_2, pdbx_initial_refinement_model Download